Every Form 4 that Inspire Medical Systems, Inc. (INSP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow INSP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INSP filings page.
Inspire Medical Systems, Inc. (symbol: INSP) is the issuer of record for a Form 4 filing submitted to the SEC. Kelly Jason P reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems, Inc. (INSP) reported that Chief Operations and Innovation Officer Jason P. Kelly received an equity compensation grant of 6,350 restricted stock units on August 31, 2026. These RSUs vest in three equal annual installments starting August 31, 2027, contingent on his continued employment, bringing his directly held common shares to 25,335.
Inspire Medical Systems, Inc. insider Jason P. Kelly, Chief Manufacturing and Quality Officer, reported a sale of 963 shares of common stock on 2026-08-07 at $59.55 per share. Following this open-market sale, Kelly directly holds 18,985 shares of Inspire Medical Systems common stock.
Inspire Medical Systems, Inc. reported that Chief People Officer Melissa Mann had shares of common stock withheld to satisfy tax obligations upon vesting of RSUs granted on July 31, 2024.
Two tax-withholding dispositions each covered 326 shares at $50.21 on July 31, 2026 and $124.54 on July 31, 2025.
CARREL MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems, Inc. reported that director Michael H. Carrel received an equity award of 5,631 restricted stock units (RSUs) on July 20, 2026. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest in three equal annual installments on the first three anniversaries of the grant date, subject to Carrel’s continued service on the board of directors through each vesting date. Following this award, he is reported as directly holding 5,631 RSUs.
Inspire Medical Systems, Inc. director Georgia Melenikiotou reported an acquisition of 344 shares of Common Stock on 2026-07-15. These shares were received at a stated price of $0.0000 per share in lieu of cash fees under the company's Non-Employee Director Compensation Policy, bringing her direct holdings to 8,329 shares.
Tansey Casey M reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems, Inc. director Casey M. Tansey reported a grant of 346 shares of common stock on July 15, 2026. The shares were received at 0.0000 per share in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. After this award, Tansey directly holds 26,632 shares and also reports indirect ownership of 500 shares held by The Kimberly Tansey Irrevocable Trust and 500 shares held by The Kylie Tansey Irrevocable Trust.
Inspire Medical Systems, Inc. director Gary Lee Ellis received an equity grant of 581 shares of common stock on July 15, 2026, reported as a grant/award acquisition. According to a footnote, these shares were issued in lieu of cash fees under the company’s Non-Employee Director Compensation Policy, at a stated price of $0.0000 per share. Following this award, Ellis directly holds 11,419 shares of Inspire Medical Systems common stock.
Broader Shelley G reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems, Inc. reported that director Shelley G. Broader received a grant of 383 shares of common stock on 2026-07-15, issued at $0.0000 per share as equity compensation in lieu of cash fees. Following this award, she directly holds 8,854 shares of the company's common stock.
Inspire Medical Systems officer John Rondoni sold 2,641 shares of Common Stock in an open-market transaction at a weighted average price of $43.28 per share. The shares were sold on May 15, 2026, and he now directly holds 27,165 shares.
Inspire Medical Systems, Inc. officer John Rondoni reported an open-market sale of 700 shares of Common Stock. The shares were sold at a weighted average price of $43.01 per share, with individual trades ranging from $43.00 to $43.03. After this transaction, he directly owns 29,806 shares.
Inspire Medical Systems director Shawn McCormick reported an open-market sale of 696 shares of Common Stock at $45.31 per share. After this sale, he holds 27,712 shares directly. A separate entry shows an additional 3,000 shares held indirectly by trust, reflecting estate or planning-related ownership.
Ellis Gary Lee reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems, Inc. director Ellis Gary Lee reported receiving an equity award of 3,562 shares of common stock in the form of Restricted Stock Units (RSUs) at no cash purchase price. Each RSU represents the right to receive one share upon vesting, which occurs on the earlier of the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, subject to continued service. Following this grant, Lee directly holds 10,838 shares of common stock.
Mead Dana G Jr. reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems, Inc. director Dana G. Mead Jr. received a grant of 3,562 shares of Common Stock in the form of Restricted Stock Units (RSUs) at no purchase price.
Each RSU represents one share of common stock and will vest on the earlier of the first anniversary of the grant date or immediately before a qualifying Change of Control, as long as he continues serving the company. Following this award, he directly holds 26,213 shares of common stock.
Tansey Casey M reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Casey M. Tansey received a grant of 3,562 shares of common stock as a stock-based award. The award is in the form of Restricted Stock Units, each representing a contingent right to receive one share of common stock, and vests based on continued service, including an anniversary-based condition.
Following this grant, Tansey holds 26,286 shares of common stock directly. In addition, 500 shares are held indirectly by The Kimberly Tansey Irrevocable Trust and 500 shares are held indirectly by The Kylie Tansey Irrevocable Trust.
Curet Myriam reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Myriam Curet received an equity award in the form of restricted stock units. She was granted 3,562 RSUs of common stock at no purchase price, each representing the right to receive one share when vested. The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, if she continues serving the company through that date. Following this award, she directly holds 6,927 shares of Inspire Medical Systems common stock.
Burks Cynthia reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Cynthia Burks received an equity grant in the form of restricted stock units. She was awarded 3,562 RSUs of common stock at no cash cost, increasing her direct holdings to 6,213 shares.
Each RSU represents a right to receive one share of common stock. The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, subject to her continued service.
Inspire Medical Systems director Shelley G. Broader received an equity grant of 3,562 Restricted Stock Units (RSUs) on common stock, with no cash paid per unit. After this award, her direct holdings total 8,471 common shares. Each RSU converts into one share if it vests.
The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a qualifying Change of Control under the company’s 2018 Incentive Award Plan, assuming Broader continues to serve the company through the applicable vesting date.
mcCormick Shawn reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Shawn McCormick reported a new equity grant. He received 3,562 shares of common stock in the form of Restricted Stock Units at no cash cost, increasing his directly held stake to 28,408 shares.
The RSUs vest on the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, as long as he continues serving the company. The filing also shows 3,000 shares held indirectly through a trust.
Inspire Medical Systems director Georgia Melenikiotou reported routine equity compensation activity. On April 30, 2026, she received 3,562 Restricted Stock Units (RSUs), each representing one future share of common stock, which vest after one year or immediately before a qualifying change of control if she remains in service.
On May 1, 2026, 50 shares of common stock were withheld by the company to cover tax obligations upon vesting of earlier RSUs, a non-market, tax-withholding disposition rather than an open-market sale. After these transactions, she directly holds 7,985 shares of Inspire Medical Systems common stock.
Broader Shelley G reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Shelley G. Broader received 342 shares of Common Stock as a stock grant. The shares were valued at $52.07 per share and were issued in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. Following this routine compensation award, Broader directly holds a total of 4,909 shares of Inspire Medical Systems Common Stock.
Inspire Medical Systems, Inc. director Georgia Melenikiotou received 307 shares of common stock as a grant classified as a “grant, award, or other acquisition.” These shares were issued at $52.07 per share in lieu of cash fees under the company’s Non-Employee Director Compensation Policy, bringing her direct holdings to 4,473 shares.
Ellis Gary Lee reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Ellis Gary Lee received 518 shares of Common Stock as a stock award. The shares were granted at a value of $52.07 per share and were received in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. Following this award, Lee directly holds 7,276 shares of Inspire Medical Systems common stock.
Tansey Casey M reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Casey M. Tansey received a grant of 308 shares of Common Stock on April 15, 2026, as stock compensation in lieu of cash fees under the company’s Non-Employee Director Compensation Policy, at a reference price of $52.07 per share.
Following this award, Tansey directly holds 22,724 shares. Additional shares are reported as held indirectly through two family irrevocable trusts, each holding 500 shares of Common Stock.
Inspire Medical Systems CEO Timothy P. Herbert reported equity awards and related tax withholding in company stock. He acquired 9,005 shares of common stock at $0.00 per share upon satisfaction of performance conditions tied to previously granted performance stock units. To cover taxes on this vesting, 4,010 shares were disposed of at $59.53 per share through share withholding, a non‑open‑market transaction. Herbert also received an award of 62,153 restricted stock units that will vest in three equal annual installments starting on February 20, 2027, each representing one share of common stock if he remains employed through the vesting dates. Following these transactions, he held 37,681 shares directly, and 63,658 shares were held indirectly by a family trust.
Inspire Medical Systems officer Bryan K. Phillips reported equity awards and related tax withholding transactions in company stock. He acquired 2,400 shares of common stock at no cost upon satisfaction of performance conditions tied to previously granted performance stock units and had 735 shares withheld at a price of $59.53 per share to cover taxes on that vesting. He also received two additional stock-based awards: 15,958 shares credited in connection with performance awards and 8,399 restricted stock units that will vest in three equal annual installments starting on February 20, 2027, subject to continued employment.
Inspire Medical Systems, Inc. reported that company officer Jason P. Kelly received an award of 15,958 shares of common stock in the form of restricted stock units. The award was granted at no cash cost.
The RSUs vest in three equal annual installments starting on February 20, 2027, and each unit converts into one share of common stock if Kelly remains continuously employed through the applicable vesting date. Following this grant, he directly holds 19,948 shares of Inspire Medical Systems common stock.
Inspire Medical Systems reported that Chief People Officer Melissa Mann acquired 15,958 shares of common stock through a grant of restricted stock units. These RSUs vest in three equal annual installments starting on February 20, 2027. Each RSU converts into one common share if she remains employed through each vesting date.
Inspire Medical Systems executive Weatherby Carlton reported equity compensation changes involving the company’s common stock. On February 20, 2026, he acquired 2,196 shares at no cost following satisfaction of performance conditions on previously granted performance stock units, and 672 shares were withheld at $59.53 per share to cover taxes on that vesting.
On the same date, he also received additional stock awards totaling tens of thousands of shares at no cost, including restricted stock units that vest in three equal annual installments beginning February 20, 2027, contingent on his continued employment. After these transactions, his directly held common stock balance increased, even after the tax-withholding disposition.
Inspire Medical Systems officer John Rondoni reported equity compensation and related tax withholding in company stock. He acquired 2,400 shares of common stock at no cost upon satisfaction of performance conditions tied to earlier performance stock units, and 15,958 additional shares through a new stock award.
To cover taxes from vesting of a performance stock unit award, 735 shares were withheld at a price of $59.53 per share. After these transactions, he directly owned 14,548 shares following the tax withholding and 30,506 shares following the new restricted stock unit award, which will vest in three equal annual installments starting February 20, 2027.
Inspire Medical Systems interim CFO Richard Buchholz disposed of 579 shares of common stock at $59.76 per share to cover taxes due on the vesting of a restricted stock unit award. After this tax-withholding disposition, he directly holds 43,988 shares and indirectly holds 1,475 shares through his son.
Inspire Medical Systems, Inc. CEO and President Herbert Timothy P. Herbert reported a tax-withholding disposition of 1,635 shares of common stock at $59.76 per share. These shares were withheld by the company to satisfy taxes related to the vesting of a restricted stock unit award.
After this transaction, he directly holds 32,686 common shares. An additional 63,658 shares are held indirectly through the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
Inspire Medical Systems, Inc. Chief People Officer Melissa Mann reported a Form 4 showing a tax-related share disposition. The company withheld 615 shares of common stock at $59.76 per share to satisfy taxes due upon vesting of a restricted stock unit award. After this withholding, she directly holds 7,651 common shares.
Inspire Medical Systems, Inc. officer John Rondoni reported a tax-related share disposition. On February 13, 2026, the company withheld 587 shares of common stock at $59.76 per share to cover taxes due on the vesting of a restricted stock unit award. After this withholding, Rondoni directly owned 12,883 common shares. This was a tax-withholding transaction, not an open-market sale.
Inspire Medical Systems, Inc. officer Jason P. Kelly reported a tax-related share disposition. On February 13, 2026, 551 shares of common stock were withheld by the company at $59.76 per share to satisfy taxes upon vesting of a restricted stock unit award. After this withholding, Kelly directly holds 3,990 shares of Inspire Medical Systems common stock.
Inspire Medical Systems, Inc. officer Carlton Weatherby reported a Form 4 showing a tax-withholding disposition of company stock. On February 13, 2026, 570 shares of common stock were withheld at $59.76 per share to cover taxes due upon vesting of a restricted stock unit award. After this withholding, Weatherby directly owned 6,560 common shares, indicating the transaction was for tax purposes rather than an open-market sale.
Inspire Medical Systems, Inc. reported that officer Bryan K. Phillips had 579 shares of common stock withheld on a tax-withholding disposition related to the vesting of a restricted stock unit award. The shares were valued at $59.76 each, leaving him with 12,491 directly held shares afterward.
Inspire Medical Systems officer Carlton Weatherby, Chief Strategy and Growth Officer, reported a tax-withholding disposition of 327 shares of common stock on February 9, 2026 at $66.33 per share. After this transaction, Weatherby directly owned 7,130 shares of Inspire Medical Systems common stock.
Phillips Bryan K reported disposition transactions in a Form 4 filing for INSP. The filing lists transactions totaling 327 shares at a weighted average price of $66.33 per share. Following the reported transactions, holdings were 13,070 shares.
Herbert Timothy P. reported disposition transactions in a Form 4 filing for INSP. The filing lists transactions totaling 968 shares at a weighted average price of $66.33 per share. Following the reported transactions, holdings were 34,321 shares.
Inspire Medical Systems, Inc. executive John Rondoni, the Chief Product and Innovation Officer, reported a tax-related share disposition. On February 9, 2026, 327 shares of common stock were withheld by the company at $66.33 per share to cover taxes on a vested restricted stock unit award. After this withholding, Rondoni directly beneficially owned 13,470 common shares.
Buchholz Richard reported disposition transactions in a Form 4 filing for INSP. The filing lists transactions totaling 327 shares at a weighted average price of $66.33 per share. Following the reported transactions, holdings were 44,567 shares.
Inspire Medical Systems, Inc. director Gary Lee Ellis reported receiving 304 shares of common stock on 01/15/2026 at a price of $96.47 per share. These shares were issued in lieu of cash fees under the company’s Non-Employee Director Compensation Policy, meaning his board compensation was taken in stock rather than cash.
After this award, Ellis beneficially owns 6,758 shares of Inspire Medical Systems common stock in direct ownership. The filing reflects routine director compensation rather than an open-market trade.
Inspire Medical Systems director reports stock compensation. Director Georgia Melenikiotou reported acquiring 180 shares of Inspire Medical Systems common stock on 01/15/2026 at a price of $96.47 per share. These shares were received in lieu of cash fees under the company’s Non-Employee Director Compensation Policy, meaning board fees were paid in stock instead of cash. Following this transaction, Melenikiotou beneficially owned 4,166 shares of Inspire Medical Systems common stock, held directly.
Inspire Medical Systems director Shelley G. Broader reported receiving company stock as part of her board compensation. On 01/15/2026, she acquired 200 shares of Inspire Medical Systems common stock at $96.47 per share, taken in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. After this grant, she beneficially owned 4,567 common shares directly.
Inspire Medical Systems director reports stock award
Director Casey M. Tansey reported receiving 181 shares of Inspire Medical Systems common stock on January 15, 2026, coded as an acquisition. The shares were valued at $96.47 each and were received in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. Following this award, Tansey holds 22,416 common shares directly.
In addition, two family trusts each hold 500 Inspire Medical Systems common shares, identified as the Kimberly Tansey Irrevocable Trust and the Kylie Tansey Irrevocable Trust, reported as indirect beneficial ownership.
Inspire Medical Systems insider trading report: Chief Product and Innovation Officer John Rondoni reported selling 109 shares of Inspire Medical Systems common stock on January 9, 2026 at a price of $100 per share. After this sale, he beneficially owns 13,797 shares of the company’s stock.
The filing notes that all sale transactions reported were made under a Rule 10b5-1 trading plan dated May 28, 2025, which is a pre-arranged plan intended to allow executives to sell shares over time. The reported holdings include 140 shares acquired through the company’s 2018 Employee Stock Purchase Plan since a prior Form 4 dated May 21, 2025.
Inspire Medical Systems, Inc. director insider sale reported
Director Shawn T. McCormick reported selling 1,200 shares of Inspire Medical Systems, Inc. common stock on 12/02/2025 at a price of $139 per share. After this transaction, he beneficially owns 24,846 shares directly and 3,000 shares indirectly through a trust. The filing notes that all sale transactions were made under a Rule 10b5-1 trading plan dated August 29, 2025, which is a pre-arranged plan for trading company stock.
Inspire Medical Systems director reports planned stock sale
A director of Inspire Medical Systems reported selling 2,000 shares of common stock on 11/28/2025 at a price of $127.48 per share. After this sale, the director beneficially owns 26,046 shares directly and 3,000 shares indirectly through a trust. The filing notes that all sale transactions were made under a Rule 10b5-1 trading plan dated August 29, 2025, which is a pre-arranged program for trading company stock.
Inspire Medical Systems, Inc. (INSP) director Myriam J. Curet, M.D. reported several small transactions in the company’s common stock on a Form 4. The filing shows open‑market purchases and sales between $77.2754 and $163.8388 per share, leaving her with 3,365 shares of common stock held directly after the last reported transaction on 08/08/2025.
The filing explains that some trades occurred inadvertently through a pooled investment vehicle that did not filter out Inspire’s securities. It also notes that a May 8, 2025 sale of 1 share at $153.2237 was matchable under Section 16(b) with a prior April 7, 2025 purchase of 1 share at $148.262. Dr. Curet paid the company $4.97, representing the full short‑swing profit from that transaction.